A SURVEY ON HEPATITIS-B VACCINATION POLICIES IN GENITOURINARY MEDICINE IN UK AND IRELAND
Citation
A. Eldalil et al., A SURVEY ON HEPATITIS-B VACCINATION POLICIES IN GENITOURINARY MEDICINE IN UK AND IRELAND, Genitourinary medicine, 71(4), 1995, pp. 251-253
Categorie Soggetti
Urology & Nephrology","Public, Environmental & Occupation Heath","Dermatology & Venereal Diseases
SICI code
0266-4348(1995)71:4<251:ASOHVP>2.0.ZU;2-#
Abstract
Objective-To applied in (GUM) departments Kingdom (UK) and Ireland wit
h regard to hepatitis B vaccination. Design-All genitourinary medicine
consultants were sent a questionnaire requesting information concerni
ng their selection criteria and the management of patients offered Hep
atitis B vaccine. If no response was obtained a second questionnaire w
as sent. The survey was carried out in 1993. Setting-AU genitourinary
medicine departments in UK and Ireland. Participants-234 consultants w
ere sent the questionnaire. 153 consultants responded. Results-Overall
, there was a 65.4% response rate to the questionnaire. Almost all gen
itourinary physicians would offer the vaccine to male homosexuals and
up to 74% offer it to all male homosexuals, intravenous drug users (IV
DU) and prostitutes. Of the genitourinary physicians, 96% agreed that
hepatitis B virus (HBV) serological markers should be checked prior to
or simultaneously with vaccination, yet there was no agreement as to
which marker should be performed. Up to 79% of consultants recalled th
e patients to check their response to vaccination but only 61% offered
long term follow up after vaccination. Conclusion-HBV vaccine is offe
red to all male homosexuals, IVDU and prostitutes in GUM departments.
Currently, the vaccine is not generally offered to patients who presen
t with sexually transmitted diseases. Almost all genitourinary physici
ans (96%) agree that HBV serological markers should be checked prior t
o or simultaneously with the start of the vaccination course and 80% w
ould request hepatitis B surface antibody levels after vaccination to
identify inadequate responders and non-responders. From this survey, t
here appears to be a need for uniform post-vaccination HBV screening a
nd timing and frequency of booster doses.